Physician profile
Richard Jason Hartman
NPI 1952533820
$6,083.43
in general payments reported to CMS, 2019-2025
24 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what 88% of Neuromusculoskeletal Medicine & Omm providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $195 · 2021: $631 · 2022: $352 · 2023: $1,753 · 2024: $1,065 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,275 · Travel and Lodging: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,274.91 |
| Travel and Lodging | $624.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $2,215.14 | 2023-2025 | Prospera, Biotronik |
| Stryker Corporation | $1,559.95 | 2019-2025 | Spinejack, Optablate, Mild Device Kit |
| Abbott Laboratories | $547.29 | 2021-2024 | Proclaim, Octrode, Eterna |
| Abbvie INC. | $340.79 | 2023-2025 | |
| Medtronic USA, INC. | $240.97 | 2019-2020 | |
| Boston Scientific Corporation | $221.79 | 2022-2025 | Intracept |
| Nevro Corp. | $169.33 | 2019-2021 | |
| Spr Therapeutics, INC | $168.00 | 2023 | Sprint Pns System |
| Medtronic, INC. | $122.17 | 2022-2025 | Accurian, Intellis Adaptivestim, Vanta Adaptivestim |
| Bioventus LLC | $87.38 | 2021 | |
| Djo, LLC | $53.85 | 2024-2025 | Aircast |
| Depuy Synthes Sales INC. | $49.40 | 2022 | |
| Virtus Pharmaceuticals LLC | $42.33 | 2023-2025 | Levorphanol Tartrate |
| Painteq LLC | $36.26 | 2022-2023 | Painteq |
| Merck Sharp & Dohme LLC | $34.76 | 2023-2024 | Bridion |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $28.76 | 2020 | |
| Chiesi USA, INC. | $25.36 | 2021 | |
| Vertiflex, INC. | $23.70 | 2019 | |
| Horizon Therapeutics Plc | $23.17 | 2022 | |
| Scilex Pharmaceuticals INC. | $22.77 | 2022 | |
| Fidia Pharma USA INC. | $21.85 | 2024 | Triluron, Hyalgan, Hymovis |
| International Rehabilitative Sciences, INC | $18.24 | 2025 | Rs-4i Plus With Intersperse |
| Ibsa Pharma INC. | $17.33 | 2023 | Tirosint, Licart |
| Zyla Life Sciences, INC. | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hartman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.